当前位置:首页 - 行情中心 - 贝达药业(300558) - 财务分析 - 现金流量表

贝达药业

(300558)

  

流通市值:204.88亿  总市值:205.44亿
流通股本:4.22亿   总股本:4.23亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,823,696,428.38951,635,104.643,588,039,269.522,647,137,175.41
  收到其他与经营活动有关的现金88,087,535.162,368,694.21102,776,288.4790,716,752.84
  经营活动现金流入小计1,911,783,963.481,014,003,798.853,690,815,557.992,737,853,928.25
  购买商品、接受劳务支付的现金243,252,107.58101,230,387.32594,275,664.03402,612,013.17
  支付给职工以及为职工支付的现金370,414,589.58231,987,033.64627,573,049.47476,111,063.84
  支付的各项税费217,591,161.37109,053,453.55262,972,266.18195,901,768.51
  支付其他与经营活动有关的现金668,186,400.87308,125,235.541,294,733,670.08994,798,835.81
  经营活动现金流出小计1,499,444,259.4750,396,110.052,779,554,649.762,069,423,681.33
  经营活动产生的现金流量净额412,339,704.08263,607,688.8911,260,908.23668,430,246.92
二、投资活动产生的现金流量:
  收回投资收到的现金175,583,451.1540,032,876.71--
  取得投资收益收到的现金--999,000999,000
  处置固定资产、无形资产和其他长期资产收回的现金净额366,238.1118,813.0975,286.0714,509.42
  投资活动现金流入小计175,949,689.2640,051,689.81,074,286.071,013,509.42
  购建固定资产、无形资产和其他长期资产支付的现金385,923,977.22351,944,820.43616,679,783.05481,735,187.19
  投资支付的现金40,000,00040,000,000312,260,000249,750,000
  投资活动现金流出小计425,923,977.22391,944,820.43928,939,783.05731,485,187.19
  投资活动产生的现金流量净额-249,974,287.96-351,893,130.63-927,865,496.98-730,471,677.77
三、筹资活动产生的现金流量:
  吸收投资收到的现金--92,166,27892,166,278
  取得借款收到的现金617,037,296.9610,000,000880,000,000680,000,000
  收到其他与筹资活动有关的现金--37,780,00037,780,000
  筹资活动现金流入小计617,037,296.9610,000,0001,009,946,278809,946,278
  偿还债务支付的现金586,070,000499,960,000818,340,000632,810,000
  分配股利、利润或偿付利息支付的现金95,436,972.6915,898,544.22150,756,175.09134,753,554.17
  支付其他与筹资活动有关的现金71,520,066.9214,326,464.9867,025,812.3439,596,154.43
  筹资活动现金流出小计753,027,039.61530,185,009.21,036,121,987.43807,159,708.6
  筹资活动产生的现金流量净额-135,989,742.7179,814,990.8-26,175,709.432,786,569.4
四、汇率变动对现金及现金等价物的影响-1,170,329.93-504,046.511,078,742.471,901,864.44
五、现金及现金等价物净增加额25,205,343.48-8,974,497.54-41,701,555.71-57,352,997.01
  加:期初现金及现金等价物余额429,981,299.41429,981,299.41471,682,855.12471,682,855.12
  期末现金及现金等价物余额455,186,642.89421,006,801.87429,981,299.41414,329,858.11
补充资料:
  净利润292,690,071.67-286,208,754.84-
  资产减值准备34,416,605.53--545,181.28-
  固定资产和投资性房地产折旧85,902,891.21-187,286,893.15-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧85,902,891.21-187,286,893.15-
  无形资产摊销192,616,432.1-360,644,562.12-
  处置固定资产、无形资产和其他长期资产的损失344,114.22--377,650.1-
  固定资产报废损失4,693.68-8,062.94-
  公允价值变动损失-72,656,728.97-58,682,848.1-
  财务费用53,595,993.28-88,251,152.52-
  投资损失27,370,062.33-20,643,530.43-
  递延所得税-12,576,291.07--16,274,634.29-
  其中:递延所得税资产减少-7,378,928.49--3,294,921.58-
    递延所得税负债增加-5,197,362.58--12,979,712.71-
  存货的减少16,846,502.7--91,593,907.31-
  经营性应收项目的减少-208,268,934.04--290,901,227.75-
  经营性应付项目的增加-4,487,751.58-256,977,937.5-
  其他4,957,949.63-49,417,510.2-
  现金的期末余额455,186,642.89-429,981,299.41-
  减:现金的期初余额429,981,299.41-471,682,855.12-
  现金及现金等价物的净增加额25,205,343.48--41,701,555.71-
公告日期2026-08-212026-04-232026-04-232025-10-28
审计意见(境内)标准无保留意见
TOP↑